Multidrug-resistant Serratia liquefaciens urinary tract infection in chronic kidney disease: a case report
This case report describes a multidrug-resistant *Serratia liquefaciens* urinary tract infection in a 66-year-old woman with chronic kidney disease, emphasizing the critical need for accurate species identification and tailored antimicrobial therapy based on susceptibility testing in high-risk patients with complicated urinary tract conditions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the human body as a bustling, high-tech city. Usually, the immune system acts like a vigilant police force, keeping unwanted invaders out. But sometimes, the city's defenses get a little worn down, or the "pipes" (like the urinary tract) develop leaks or blockages. This is where microscopic troublemakers, known as bacteria, can sneak in. Most of the time, we have powerful "super-soakers" called antibiotics to wash these germs away. However, some bacteria are like master locksmiths; they have learned to pick the locks on almost every bottle of medicine we have. This is called "multidrug resistance," and it's a scary problem for doctors because it leaves them with very few tools to stop an infection. When this happens in a patient whose kidneys are already struggling to filter waste, it becomes a medical emergency where every choice matters.
This story is about a specific, rare germ called Serratia liquefaciens. While its cousin, Serratia marcescens, is a more famous troublemaker in hospitals, Serratia liquefaciens is like a shy, rarely seen ghost that usually hides in the background. It's an opportunistic germ, meaning it waits for a weak spot to strike. This paper tells the story of a 66-year-old woman who had a perfect storm of health issues: her kidneys were already failing (chronic kidney disease), her urinary system was full of twists and turns (non-obstructive uropathy and hydronephrosis), and she had been in the hospital many times before. She came in feeling weak, with urine that was cloudy and smelled terrible. Doctors found she had severe anemia and her kidneys were working at a standstill, with a creatinine level of 13.2 mg/dL and blood urea of 181 mg/dL.
The real drama began when the lab tested her urine. Instead of the usual suspects, they found this rare Serratia liquefaciens. But here is the twist: this wasn't just any germ; it was a "super-bug." When the doctors tested it against a wide variety of antibiotics, the germ laughed at almost all of them. It was resistant to beta-lactams, cephalosporins, carbapenems (the heavy hitters), gentamicin, ciprofloxacin, and trimethoprim-sulfamethoxazole. In fact, the list of drugs that failed was long enough to fill a small notebook. The only weapons that seemed to work were tigecycline, fosfomycin, and colistin.
The paper doesn't just list these facts; it argues that finding this rare germ in the urine wasn't a mistake or a contaminant. Because the patient had such clear symptoms, pus cells in her urine, and X-rays showing inflammation in her kidneys (pyelitis) and bladder (cystitis), the authors are confident this germ was the actual villain. They ruled out the idea that it was just a harmless passenger because the blood culture came back clean, meaning the infection was stuck in the urinary tract and hadn't spread to the bloodstream.
The authors suggest that this case is a warning sign. They show that in patients with complex kidney issues and a history of hospital visits, even rare germs like Serratia liquefaciens can cause serious, hard-to-treat infections. The paper concludes that doctors need to be extra careful. They must identify the germ down to the specific species level (not just the genus) and look closely at which drugs will actually work, especially when the patient's kidneys can't handle strong medications. It's a reminder that in the battle against these microscopic locksmiths, knowing exactly who the enemy is and which key fits the lock is the only way to win.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.